Long Term Growth Stock in Review: Epizyme, Inc. (NASDAQ:EPZM)

Shaers of Epizyme, Inc. (NASDAQ:EPZM) have been recommended as a long term growth pick.  With the firm’s stock price currently trading around $15.55, the firm has proven a solid track record of growth over the recent years.  Investors might consider the stock as a long term growth candidate as the firm has yielded 33.30% earnings per share growth over the past 5 years and 2.90% revenue growth over that same time frame. 

Long-term growth (LTG) is an investing strategy where a stock will (hopefully) grow in value for a relatively long period of time.  A “buy-and-hold” investor will consider long-term growth as a longer time period then a day trader will. The buy-and-hold strategy looks ahead farther into the future, giving short-term price swings less consideration as long as the fundamentals stay the same.  

Let’s take a look at how the stock has been performing recently.  Over the past twelve months, Epizyme, Inc. (NASDAQ:EPZM)’s stock was 23.90%.  Over the last week of the month, it was 17.80%, -13.37% over the last quarter, and  2.30% for the past six months. 

Over the past 50 days, Epizyme, Inc.’s stock is -9.46% off of the high and 37.00% removed from the low.  Their 52-Week High and Low are as follows: -23.96% (High), 67.20%, (Low). 

Despite the past success, investors want to know where the stock is headed from here.  Analysts covering the shares have a consensus short-term price target of $22.67 on the equity.   Analysts have a consensus recommendation of 1.60 based on a 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.  

Leave a Comment